drugset / Trial / NCT01241864

Islet Transplantation in Type 1 Diabetic Kidney Allograft

NCT01241864 ↗

Phase 2 Recruiting 10 enrolled University of Chicago
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to learn about the safety of islet transplantation when performed after kidney transplantation, which may provide more normal control of blood sugar without the need for insulin shots. Islets are special clusters of cells within the pancreas that produce insulin. These cells will be obtained from cadaver (non-living) donors and given to subjects by vein.

Timeline

Start
2010-12
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Allogenic islet cells Cell therapy — Other